Order
Virus Genome Detection - SARS-CoV-2 sequence analysis (417)
Samples:
3-5 samples of 1.5 ml
Sample properties:
Lyophilised cell culture material (inactivated)
Additional Information:
Cooperation with:
Nationales Konsiliarlabor für Coronaviren, Institut für Virologie, Charité – Universitätsmedizin Berlin;
Medizinisches Infektiologiezentrum Berlin;
Abt. Methodenentwicklung und Forschungsinfrastruktur, Robert Koch-Institut, Berlin
Requirement for EQAS/PT according to Rili-BÄK
Certificate Validity: not applicable
Not subject to Rili-BÄK
Parameters:
Differentiation of SARS-CoV-2 variants with clinical relevance using whole genome sequencing
Please note:
Submitted sequences are evaluated for sequence quality both in the S gene and separately in the whole genome.
Certificate Validity: not applicable
Shipping Information:
Shipping not cooled
Safety Information:
Process as patient sample material
Dates:
Registration deadline:
Sample shipment:
Closing Date:
| Apr. (2) | Sep. (5) |
|---|---|
| 08.01.2027 | 25.06.2027 |
| 09.03.2027 | 24.08.2027 |
| 09.04.2027 | 24.09.2027 |
EQAS/PT Experts:
Dr. med. Martin Obermeier
MVZ medizinisches Infektiologiezentrum Berlin AG
Oudenarder Strasse 16
13347 Berlin
+49 30-34409104-66
obermeier@mvz-mib.de
Dr. rer. nat. Martin Kammel
Institut für Qualitätssicherung in der Virusdiagnostik - IQVD
Potsdamer Chaussee 80
14129 Berlin
+49 30 8105 4300
m.kammel@iqvd.de